Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Navitoclax in SCLC and Other Solid Tumors
NCT00445198Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Apr 2007
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of navitoclax in small cell lung cancer (SCLC), solid tumor, sponsored by AbbVie Inc.. Started Apr 2007; status: completed.
02
Drugs
navitoclax
03
Conditions
small cell lung cancer (SCLC)solid tumor
Beyond the preview
Go deeper on NCT00445198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00445198.